Quarterly report pursuant to Section 13 or 15(d)

Summary of Outstanding Stock Options and Changes (Details)

v3.21.2
Summary of Outstanding Stock Options and Changes (Details)
 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Options, Beginning Balance | shares 4,188,315
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 2.59
Weighted Average Remaining Contractual Term (Years), Beginning 2 years 3 months 14 days
Aggregate Intrinsic Value, Beginning Balance | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (Years), Granted
Aggregate Intrinsic Value, Granted | $
Number of Options, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Weighted Average Remaining Contractual Term (Years), Forfeited
Aggregate Intrinsic Value, Forfeited | $
Number of Options, Canceled/Expired | shares
Weighted Average Exercise Price, Canceled/Expired | $ / shares
Weighted Average Remaining Contractual Term (Years), Canceled/Expired
Aggregate Intrinsic Value, Canceled/Expired | $
Number of Options, Ending Balance | shares 4,188,315
Weighted Average Exercise Price, Ending Balance | $ / shares $ 2.59
Weighted Average Remaining Contractual Term (Years), Ending 1 year 6 months 14 days
Aggregate Intrinsic Value, Ending Balance | $ $ 19,308,132
Number of Options, Exercisable | shares 4,188,315
Weighted Average Exercise Price, Exercisable | $ / shares $ 2.59
Weighted Average Remaining Contractual Term (Years), Exercisable 1 year 6 months 14 days
Aggregate Intrinsic Value, Exercisable | $ $ 19,308,132